IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

In the media

Proliferative and invasive capacity of tumour cells (centre) compared to normal cells (left) and effect of TRAMETINIB treatment, which reduces the invasive capacity and tumoural load (right). Marco Milán, IRB Barcelona.
Media mentions
Advancing in the battle against cancer
Valentina Maria Zinna, Salvador Aznar Benitah, Patrick Welz and Inés Marín Guillén, IRB Barcelona.
Media mentions
Each organ can tell what time it is independently of the brain
Antonio Zorzano and his team at the Complex Metabolic Diseases and Mitochondria Lab have participated in this study. IRB Barcelona.
Media mentions
A potential target to treat non-alcoholic fatty liver
Structure of EGFR. Purple indicates the region recognised by mAB806. Laura Orellana.
Media mentions
New approaches for the treatment of cancer
Structure of the BasC transporter.
Media mentions
Characterisation of the structure and function of an L-amino acid transporter
Francesc Posas, director of IRB Barcelona, during his participation on TV3’s “Els Matins” programme.
Media mentions
Donations on the rise in Catalonia
Magdalena Socias, cancer patient.
Media mentions
Magdalena Socias joins the #MetastasisChallenge through her initiative to walk La Serra de Tramuntana
Angel R. Nebreda, head of the Signalling and Cell Cycle Laboratory at IRB Barcelona
Media mentions
Discovering therapies that do not cause resistance, one of the challenges of cancer research
Press conference at IRB Barcelona, presenting the #MetastasisChallenge
Media mentions
IRB Barcelona wants to raise €5 M for research into metastasis